FollowTheFilings
Managers
Activity
Compare
Newest
Investment
NEKTAR THERAPEUTICS
Historical 13F holders
CUSIP
640268306
Type
Equity
Class
COM NEW
Period
13F filings
2026 Q1
6
2025 Q4
10
2025 Q3
11
2025 Q2
7